KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
פורמט: | Conference item |
יצא לאור: |
2012
|
סיכום: |
---|